search
Back to results

Mindful Movement in Women Receiving Adjuvant or Neoadjuvant Therapy for Breast Cancer

Primary Purpose

Breast Cancer, Cancer of Breast

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Yoga
Blood draw
FACT-G questionnaire
Weight measurement
Recent Physical Activity Questionnaire
NHANES Food Questionnaire
Sponsored by
Washington University School of Medicine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Breast Cancer

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Eligibility Critera:

  • Age ≥ 18.
  • Female.
  • Newly diagnosed with Stage I-III breast cancer.
  • Scheduled to undergo neoadjuvant or adjuvant chemotherapy or neoadjuvant endocrine therapy.
  • Not currently regularly practicing yoga (defined as at least once a month).
  • Able to read and understand English
  • Able to understand and willing to sign an IRB-approved written informed consent document

Sites / Locations

  • Washington University School of Medicine

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Arm 1: Yoga

Arm 2: No Yoga

Arm Description

Prior to start of treatment, a yoga therapist will work with each patient to develop a personalized yoga protocol using Gentle Hatha and Restorative Yoga Each protocol will consist of 5-10 minutes of centering poses to invite focus and relaxation, then 15-20 minutes of seated and standing active poses, ending with 5-10 minutes of guided relaxation. The personalized practice will be given to each participant and she will be asked to practice beginning at the start of neoadjuvant treatment at least 3 times a week (but preferably daily) at home for at least 30 minutes each time. Participants will continue their personalized yoga practice during the entirety of treatment. Each participant will be asked to journal when and for how long she practices at home and make any comments as to how the practice might have made her feel During participation, weekly follow-up calls will be made by a member of the study team to each participant randomized to the yoga arm.

-Patients in this arm will not receive a personalized yoga plan

Outcomes

Primary Outcome Measures

Feasibility of enrolling patients to larger randomized controlled trial using yoga and mindful movement as measured the number of eligible patients enrolled
-Feasibility is defined as the ability to enroll 60% of eligible patients
Feasibility of conducting a larger randomized trial using yoga and mindful movement
-Feasibility is defined as the ability to have an 80% completion rate of the intervention
Efficacy of yoga exercise as measured by weight change from baseline to completion

Secondary Outcome Measures

Effect of yoga exercise as measured by rate of pathologic response (partial and complete) (neoadjuvant subset only)
Effect of yoga exercise as measured by inflammatory markers
Effect of yoga exercise as measured by fatigue index
-Fatigue index will be measured by FACT-G questionnaire
Effect of yoga exercise as measured by quality of life
-Quality of life will be measured by FACT-G questionnaire

Full Information

First Posted
August 23, 2017
Last Updated
August 29, 2019
Sponsor
Washington University School of Medicine
Collaborators
The Foundation for Barnes-Jewish Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03262831
Brief Title
Mindful Movement in Women Receiving Adjuvant or Neoadjuvant Therapy for Breast Cancer
Official Title
The Role of Mindful Movement in Women Receiving Adjuvant or Neoadjuvant Therapy for Breast Cancer
Study Type
Interventional

2. Study Status

Record Verification Date
August 2019
Overall Recruitment Status
Completed
Study Start Date
January 10, 2018 (Actual)
Primary Completion Date
June 26, 2019 (Actual)
Study Completion Date
June 26, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Washington University School of Medicine
Collaborators
The Foundation for Barnes-Jewish Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The investigators hypothesize that a personalized yoga program with mindful movement implemented during breast cancer therapy will benefit women in multiple ways. The investigators predict that women participating in the program will experience less weight gain and fatigue and will have an improved quality of life compared to women not participating in the program. The investigators predict that this will be associated with decreased markers of inflammation. The investigators will also evaluate whether there is improved pathologic response rate compared to historical controls. This study will provide pilot data for a larger randomized controlled trial assessing whether program can provide long-term improvement in quality of life, weight maintenance, and the serum and tumor changes correlating with a reduced risk of recurrence and mortality.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer, Cancer of Breast

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Arm 1: Yoga
Arm Type
Experimental
Arm Description
Prior to start of treatment, a yoga therapist will work with each patient to develop a personalized yoga protocol using Gentle Hatha and Restorative Yoga Each protocol will consist of 5-10 minutes of centering poses to invite focus and relaxation, then 15-20 minutes of seated and standing active poses, ending with 5-10 minutes of guided relaxation. The personalized practice will be given to each participant and she will be asked to practice beginning at the start of neoadjuvant treatment at least 3 times a week (but preferably daily) at home for at least 30 minutes each time. Participants will continue their personalized yoga practice during the entirety of treatment. Each participant will be asked to journal when and for how long she practices at home and make any comments as to how the practice might have made her feel During participation, weekly follow-up calls will be made by a member of the study team to each participant randomized to the yoga arm.
Arm Title
Arm 2: No Yoga
Arm Type
Active Comparator
Arm Description
-Patients in this arm will not receive a personalized yoga plan
Intervention Type
Other
Intervention Name(s)
Yoga
Intervention Description
The yoga practice, Gentle Hatha and Restorative Yoga, will be based on protocols that have been found to decease fatigue and weight gain by helping the participant gain insight in recognizing stress responses and ways to relax
Intervention Type
Procedure
Intervention Name(s)
Blood draw
Intervention Description
Baseline and end of treatment To evaluate change in inflammatory markers (CRP, IL-6, and TNF)
Intervention Type
Behavioral
Intervention Name(s)
FACT-G questionnaire
Intervention Description
7 statements that other people with breast cancer have said are important, the patient is to circle or mark one number per line to indicate the response as it applies in the last 7 days Answers range from 0=not at all to 4=very much
Intervention Type
Procedure
Intervention Name(s)
Weight measurement
Intervention Description
-Weight will be taken at baseline, on day 1 of each cycle, and the end of treatment
Intervention Type
Behavioral
Intervention Name(s)
Recent Physical Activity Questionnaire
Other Intervention Name(s)
RPAQ
Intervention Description
-To assess physical activity, the RPAQ will be completed at baseline and at the end of treatment.
Intervention Type
Behavioral
Intervention Name(s)
NHANES Food Questionnaire
Intervention Description
-To assess diet, the NHANES Food Questionnaire will be completed at baseline and at the end of treatment.
Primary Outcome Measure Information:
Title
Feasibility of enrolling patients to larger randomized controlled trial using yoga and mindful movement as measured the number of eligible patients enrolled
Description
-Feasibility is defined as the ability to enroll 60% of eligible patients
Time Frame
Completion of study enrollment (estimated to be 6 months)
Title
Feasibility of conducting a larger randomized trial using yoga and mindful movement
Description
-Feasibility is defined as the ability to have an 80% completion rate of the intervention
Time Frame
Completion of study enrollment (estimated to be 6 months)
Title
Efficacy of yoga exercise as measured by weight change from baseline to completion
Time Frame
Completion of treatment (estimated to be 6 months)
Secondary Outcome Measure Information:
Title
Effect of yoga exercise as measured by rate of pathologic response (partial and complete) (neoadjuvant subset only)
Time Frame
Completion of treatment (estimated to be 6 months)
Title
Effect of yoga exercise as measured by inflammatory markers
Time Frame
Completion of treatment (estimated to be 6 months)
Title
Effect of yoga exercise as measured by fatigue index
Description
-Fatigue index will be measured by FACT-G questionnaire
Time Frame
Completion of treatment (estimated to be 6 months)
Title
Effect of yoga exercise as measured by quality of life
Description
-Quality of life will be measured by FACT-G questionnaire
Time Frame
Completion of treatment (estimated to be 6 months)

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Eligibility Critera: Age ≥ 18. Female. Newly diagnosed with Stage I-III breast cancer. Scheduled to undergo neoadjuvant or adjuvant chemotherapy or neoadjuvant endocrine therapy. Not currently regularly practicing yoga (defined as at least once a month). Able to read and understand English Able to understand and willing to sign an IRB-approved written informed consent document
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lindsay L Peterson, M.D., MSCR
Organizational Affiliation
Washington University School of Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Washington University School of Medicine
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63110
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Links:
URL
http://www.siteman.wustl.edu
Description
Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

Learn more about this trial

Mindful Movement in Women Receiving Adjuvant or Neoadjuvant Therapy for Breast Cancer

We'll reach out to this number within 24 hrs